Journal of Biological Chemistry · 2008 · 106 citations · 56 references
Life SciencesBiochemistryMolecular BiologyChromatin BiologyPost-translational ModificationTranscriptional RegulationEpigenetic AlterationsHistone ModificationsHistone Post-translational ModificationsPost-translational RegulationPromoter RegulationCcaat/enhancer-binding Protein RegulationHistone MethylationHistone Methylation At Lysine 9Histone MethyltransferasesHistone Modifications At EnhancersHistone-lysine MethylationLysine Methyltransferase ActivityMethylation Reactions
The functional capacity of the transcriptional regulatory CCAAT/enhancer-binding protein-β (C/EBPβ) is governed by protein interactions and post-translational protein modifications. In a proteome-wide interaction screen, the histone-lysine N-methyltransferase, H3 lysine 9-specific 3 (G9a), was found to directly interact with the C/EBPβ transactivation domain (TAD). Binding between G9a and C/EBPβ was confirmed by glutathione S-transferase pulldown and co-immunoprecipitation. Metabolic labeling showed that C/EBPβ is post-translationally modified by methylation in vivo. A conserved lysine residue in the C/EBPβ TAD served as a substrate for G9a-mediated methylation. G9a, but not a methyltransferase-defective G9a mutant, abrogated the transactivation potential of wild type C/EBPβ. A C/EBPβ TAD mutant that contained a lysine-to-alanine exchange was resistant to G9a-mediated inhibition. Moreover, the same mutation conferred super-activation of a chromatin-embedded, endogenous C/EBPβ target gene. Our data identify C/EBPβ as a direct substrate of G9a-mediated post-translational modification that alters the functional properties of C/EBPβ during gene regulation. The functional capacity of the transcriptional regulatory CCAAT/enhancer-binding protein-β (C/EBPβ) is governed by protein interactions and post-translational protein modifications. In a proteome-wide interaction screen, the histone-lysine N-methyltransferase, H3 lysine 9-specific 3 (G9a), was found to directly interact with the C/EBPβ transactivation domain (TAD). Binding between G9a and C/EBPβ was confirmed by glutathione S-transferase pulldown and co-immunoprecipitation. Metabolic labeling showed that C/EBPβ is post-translationally modified by methylation in vivo. A conserved lysine residue in the C/EBPβ TAD served as a substrate for G9a-mediated methylation. G9a, but not a methyltransferase-defective G9a mutant, abrogated the transactivation potential of wild type C/EBPβ. A C/EBPβ TAD mutant that contained a lysine-to-alanine exchange was resistant to G9a-mediated inhibition. Moreover, the same mutation conferred super-activation of a chromatin-embedded, endogenous C/EBPβ target gene. Our data identify C/EBPβ as a direct substrate of G9a-mediated post-translational modification that alters the functional properties of C/EBPβ during gene regulation. CCAAT/enhancer-binding protein-β (C/EBPβ) 2The abbreviations used are: C/EBPβCCAAT/enhancer-binding protein-βGSTglutathione S-transferasePCAFp300/CREB-binding protein associated factorAAamino acid(s)PMAphorbol 12-myristate 13-acetateGFPgreen fluorescent proteinIPimmunoprecipitationMES4-morpholineethanesulfonic acidTADtransactivation domainCRconserved regionPKAprotein kinase A. 2The abbreviations used are: C/EBPβCCAAT/enhancer-binding protein-βGSTglutathione S-transferasePCAFp300/CREB-binding protein associated factorAAamino acid(s)PMAphorbol 12-myristate 13-acetateGFPgreen fluorescent proteinIPimmunoprecipitationMES4-morpholineethanesulfonic acidTADtransactivation domainCRconserved regionPKAprotein kinase A. is a basic leucine zipper transcription factor that regulates tissue-specific gene expression, proliferation, and differentiation in a variety of cell types. C/EBPβ is an important factor for female reproduction (1Sterneck E. Tessarollo L. Johnson P.F. Genes Dev. 1997; 11: 2153-2162Crossref PubMed Scopus (342) Google Scholar), liver function and regeneration (2Greenbaum L.E. Li W. Cressman D.E. Peng Y. Ciliberto G. Poli V. Taub R. J. Clin. Investig. 1998; 102: 996-1007Crossref PubMed Scopus (232) Google Scholar), acute phase response (3Poli V. J. Biol. Chem. 1998; 273: 29279-29282Abstract Full Text Full Text PDF PubMed Scopus (552) Google Scholar), as well as innate and adopted immune functions (4Tanaka T. Akira S. Yoshida K. Umemoto M. Yoneda Y. Shirafuji N. Fujiwara H. Suematsu S. Yoshida N. Kishimoto T. Cell. 1995; 80: 353-361Abstract Full Text PDF PubMed Scopus (466) Google Scholar). CCAAT/enhancer-binding protein-β glutathione S-transferase p300/CREB-binding protein associated factor amino acid(s) phorbol 12-myristate 13-acetate green fluorescent protein immunoprecipitation 4-morpholineethanesulfonic acid transactivation domain conserved region protein kinase A. CCAAT/enhancer-binding protein-β glutathione S-transferase p300/CREB-binding protein associated factor amino acid(s) phorbol 12-myristate 13-acetate green fluorescent protein immunoprecipitation 4-morpholineethanesulfonic acid transactivation domain conserved region protein kinase A. Although the locus encoding C/EBPβ lacks any intron, three protein isoforms are generated from a single mRNA transcript by alternative translation initiation, resulting in full-length and N-terminally truncated proteins termed LAP*, LAP, and LIP proteins, respectively (5Descombes P. Schibler U. Cell. 1991; 67: 569-579Abstract Full Text PDF PubMed Scopus (857) Google Scholar, 6Calkhoven C.F. Muller C. Leutz A. Genes Dev. 2000; 14: 1920-1932PubMed Google Scholar). The long C/EBPβ isoforms LAP* and LAP are transactivator proteins, and the small LIP isoform is thought of as a transcriptional dominant-negative inhibitor, although LAP may also function as a latent transcriptional repressor dependent on post-translational modifications (7Screpanti I. Musiani P. Bellavia D. Cappelletti M. Aiello F.B. Maroder M. Frati L. Modesti A. Gulino A. Poli V. J. Exp. Med. 1996; 184: 1561-1566Crossref PubMed Scopus (57) Google Scholar, 8Lamb J. Ramaswamy S. Ford H.L. Contreras B. Martinez R.V. Kittrell F.S. Zahnow C.A. Patterson N. Golub T.R. Ewen M.E. Cell. 2003; 114: 323-334Abstract Full Text Full Text PDF PubMed Scopus (359) Google Scholar). A number of post-translational modifications have been detected on C/EBPβ, including phosphorylation, acetylation, and SUMOylation. Of particular interest is a phosphoacceptor site in the central, regulatory part of the protein that is conserved throughout evolution (Thr-235 in human (9Nakajima T. Kinoshita S. Sasagawa T. Sasaki K. Naruto M. Kishimoto T. Akira S. Proc. Natl. Acad. Sci. U. S. A. 1993; 90: 2207-2211Crossref PubMed Scopus (514) Google Scholar), Thr-188 in rat (10Hanlon M. Sturgill T.W. Sealy L. J. Biol. Chem. 2001; 276: 38449-38456Abstract Full Text Full Text PDF PubMed Scopus (56) Google Scholar), and Thr-220 in chicken (11Kowenz-Leutz E. Twamley G. Ansieau S. Leutz A. Genes Dev. 1994; 8: 2781-2791Crossref PubMed Scopus (209) Google Scholar)). Phosphorylation at this site creates a conformational change that abrogates the inhibitory function of the central regulatory domain. This leads to a release of the N-terminal transactivation domain (TAD) (11Kowenz-Leutz E. Twamley G. Ansieau S. Leutz A. Genes Dev. 1994; 8: 2781-2791Crossref PubMed Scopus (209) Google Scholar, 12Williams S.C. Baer M. Dillner A.J. Johnson P.F. EMBO J. 1995; 14: 3170-3183Crossref PubMed Scopus (199) Google Scholar) and exchange of interacting Mediator components and activation of the repressed protein (13Mo X. Kowenz-Leutz E. Xu H. Leutz A. Mol. Cell. 2004; 13: 241-250Abstract Full Text Full Text PDF PubMed Scopus (136) Google Scholar). Other phosphorylation sites and their corresponding kinases were also identified, including glycogen synthase kinase 3 (GSK-3) that phosphorylates Ser-184 in murine LAP (Ser-33 in LIP) (14Piwien-Pilipuk G. Van Mater D. Ross S.E. MacDougald O.A. Schwartz J. J. Biol. Chem. 2001; 276: 19664-19671Abstract Full Text Full Text PDF PubMed Scopus (87) Google Scholar); calcium/calmodulin-dependent protein kinase that phosphorylates Ser-276 (15Wegner M. Cao Z. Rosenfeld M.G. Science. 1992; 256: 370-373Crossref PubMed Scopus (306) Google Scholar); and protein kinase C that phosphorylates Ser-105 and Ser-240 and protein kinase A (PKA) that phosphorylates Ser-105, Ser-299, and Ser-240 in LAP (16Chinery R. Brockman J.A. Dransfield D.T. Coffey R.J. J. Biol. Chem. 1997; 272: 30356-30361Abstract Full Text Full Text PDF PubMed Scopus (114) Google Scholar, 17Trautwein C. van der Geer P. Karin M. Hunter T. Chojkier M. J. Clin. Investig. 1994; 93: 2554-2561Crossref PubMed Scopus (128) Google Scholar, 18Trautwein C. Caelles C. van der Geer P. Hunter T. Karin M. Chojkier M. Nature. 1993; 364: 544-547Crossref PubMed Scopus (293) Google Scholar); p90 ribosomal S kinase (p90rsk) that phosphorylates Ser-105 in rat C/EBPβ and Thr-217 in murine LAP (19Buck M. Poli V. van der Geer P. Chojkier M. Hunter T. Mol. Cell. 1999; 4: 1087-1092Abstract Full Text Full Text PDF PubMed Scopus (156) Google Scholar); and Cdk2 and Cdc2 that phosphorylate Ser-64 and Thr-189 in murine C/EBPβ (20Shuman J.D. Sebastian T. Kaldis P. Copeland T.D. Zhu S. Smart R.C. Johnson P.F. Mol. Cell. Biol. 2004; 24: 7380-7391Crossref PubMed Scopus (66) Google Scholar). Several of these phosphorylation events may also depend on each other (21Li X. Kim J.W. Gronborg M. Urlaub H. Lane M.D. Tang Q.Q. Proc. Natl. Acad. Sci. U. S. A. 2007; 104: 11597-11602Crossref PubMed Scopus (85) Google Scholar) to modulate the transcriptional activity of C/EBPβ in response to external stimuli. C/EBPβ, as well as other C/EBP proteins, is also modified by SUMOylation. SUMOylation of C/EBPα (22Subramanian L. Benson M.D. Iniguez-Lluhi J.A. J. Biol. Chem. 2003; 278: 9134-9141Abstract Full Text Full Text PDF PubMed Scopus (128) Google Scholar), C/EBPβ (23Berberich-Siebelt F. Berberich I. Andrulis M. Santner-Nanan B. Jha M.K. Klein-Hessling S. Schimpl A. Serfling E. J. Immunol. 2006; 176: 4843-4851Crossref PubMed Scopus (36) Google Scholar, 24Eaton E.M. Sealy L. J. Biol. Chem. 2003; 278: 33416-33421Abstract Full Text Full Text PDF PubMed Scopus (79) Google Scholar), and C/EBPϵ (25Kim J. Cantwell C.A. Johnson P.F. Pfarr C.M. Williams S.C. J. Biol. Chem. 2002; 277: 38037-38044Abstract Full Text Full Text PDF PubMed Scopus (134) Google Scholar) occurs at a highly conserved lysine residue in the regulatory domain. Mutation of the lysine acceptor site increases the activity of the respective transcription factor, suggesting that SUMOylation is involved in repressive C/EBP functions. In addition, C/EBPβ can be acetylated at multiple lysine residues (26Cesena T.I. Cardinaux J.R. Kwok R. Schwartz J. J. Biol. Chem. 2007; 282: 956-967Abstract Full Text Full Text PDF PubMed Scopus (79) Google Scholar, 27Joo M. Park G.Y. Wright J.G. Blackwell T.S. Atchison M.L. Christman J.W. J. Biol. Chem. 2004; 279: 6658-6665Abstract Full Text Full Text PDF PubMed Scopus (47) Google Scholar, 28Xu M. Nie L. Kim S.H. Sun X.H. EMBO J. 2003; 22: 893-904Crossref PubMed Scopus (130) Google Scholar). The acetyltransferases p300 and p300/CREB-binding protein-associated factor (PCAF) catalyze acetylation of lysine 39, and mutation of lysine 39 has been shown to affect C/EBPβ-dependent reporter activity (26Cesena T.I. Cardinaux J.R. Kwok R. Schwartz J. J. Biol. Chem. 2007; 282: 956-967Abstract Full Text Full Text PDF PubMed Scopus (79) Google Scholar). Acetylation is predominantly observed on N-terminal histone tails (29Allfrey V.G. Faulkner R. Mirsky A.E. Proc. Natl. Acad. Sci. U. S. A. 1964; 51: 786-794Crossref PubMed Scopus (1727) Google Scholar) and accompanied by methylation of lysine side chains (30Comb D.G. Sarkar N. Pinzino C.J. J. Biol. Chem. 1966; 241: 1857-1862Abstract Full Text PDF PubMed Google Scholar). Methylation is involved in gene activation or gene repression depending on the state of methylation (mono-, di-, or trimethylation) and on its position on the histone tail (31Jenuwein T. Allis C.D. Science. 2001; 293: 1074-1080Crossref PubMed Scopus (7575) Google Scholar). Lysine methylation of non-histone transcription factors and the concomitant alteration of their biological functions remain poorly investigated, with some notable exceptions, such as p53 (32Chuikov S. Kurash J.K. Wilson J.R. Xiao B. Justin N. Ivanov G.S. McKinney K. Tempst P. Prives C. Gamblin S.J. Barlev N.A. Reinberg D. Nature. 2004; 432: 353-360Crossref PubMed Scopus (626) Google Scholar, 33Huang J. Perez-Burgos L. Placek B.J. Sengupta R. Richter M. Dorsey J.A. Kubicek S. Opravil S. Jenuwein T. Berger S.L. Nature. 2006; 444: 629-632Crossref PubMed Scopus (479) Google Scholar, 34Shi X. Kachirskaia I. Yamaguchi H. West L.E. Wen H. Wang E.W. Dutta S. Appella E. Gozani O. Mol. Cell. 2007; 27: 636-646Abstract Full Text Full Text PDF PubMed Scopus (334) Google Scholar). In support of a role of G9a to methylate non-histone targets, it was shown that G9a is automethylated, which raises the possibility of the enzymatic activity of G9a being utilized by other nuclear proteins S.C. I. I. A. E. A. Mol. Cell. 2007; 27: Full Text Full Text PDF PubMed Scopus Google Scholar). by G9a is thought to an on and non-histone proteins M. J. D. S. 2007; PubMed Scopus (87) Google Scholar). observed that C/EBPβ is also post-translationally and to identify interacting proteins that may the C/EBPβ and its activity in gene regulation. that G9a to the TAD of C/EBPβ, C/EBPβ on lysine 39, and alters the transcriptional capacity of C/EBPβ. of C/EBPβ and of G9a that methylation at lysine 39 the of C/EBPβ to gene of amino acid residues in C/EBPβ is on the chicken number The conserved and corresponding amino in C/EBPβ were (11Kowenz-Leutz E. Twamley G. Ansieau S. Leutz A. Genes Dev. 1994; 8: 2781-2791Crossref PubMed Scopus (209) Google Scholar). conserved region to to to to to to to and leucine zipper to were the and confirmed by were (11Kowenz-Leutz E. Twamley G. Ansieau S. Leutz A. Genes Dev. 1994; 8: 2781-2791Crossref PubMed Scopus (209) Google Scholar). the domain was from the I. M. PubMed Scopus Google Scholar) by a site with the C/EBPβ site in the at the and an at the and C/EBPβ TAD were as to the domain. for full-length and mutant G9a have been H. Proc. Natl. Acad. Sci. U. S. A. 2004; PubMed Scopus Google Scholar). the C/EBPβ TAD were and are from the and S-transferase proteins were in and with pulldown proteins were to and with in and were in modified and at and and were in and at and H. G. C. T. J. Cell. PubMed Scopus (128) Google Scholar) were with chicken and at and 12-myristate 13-acetate was for at a of were by the or with and were or C/EBPβ fluorescent protein and or were in and were with for at and were on protein or was used for were and or on the or by immunoprecipitation was as with T. Mol. Cell. Biol. 2001; PubMed Scopus Google Scholar). were with with and and was by were and and was by the of the was by of and was with of the of the was for were with protein protein were with and and and 3 and and with of and were by in at were with and was by was and a to the was with of are J. S. M. M. 2006; PubMed Scopus Google Scholar). In or was the were and and proteins were from for 3 with an were by protein and used directly in the was with of as a and of protein or of the corresponding were for 3 at in and M. D. S. PubMed Scopus Google Scholar). were to and detected by or and was by In were with in the or of in modified with the protein and as G. Mol. Cell. Biol. 1995; PubMed Scopus Google Scholar). of translation was by labeling the with C/EBPβ was and by were with and to at chicken factor or a site was used E. C. T. Leutz A. Mol. Cell. Biol. 1992; PubMed Scopus Google Scholar, E. Muller C. S. Leutz A. EMBO J. 1992; 11: PubMed Scopus Google Scholar). C/EBPβ were with a reporter in the and of were and and reporter were in in a reporter were to as by gene activation was by of and as (11Kowenz-Leutz E. Twamley G. Ansieau S. Leutz A. Genes Dev. 1994; 8: 2781-2791Crossref PubMed Scopus (209) Google Scholar). human protein was the C/EBPβ TAD as a The was generated as a protein in The protein was with from and the was by The was in by in kinase and in the of The protein was in in to the on proteins were by of was to the C/EBPβ with the G9a Lysine C/EBPβ protein for was to identify proteins that interact with the TAD of C/EBPβ the of C/EBPβ the TAD of (11Kowenz-Leutz E. Twamley G. Ansieau S. Leutz A. Genes Dev. 1994; 8: 2781-2791Crossref PubMed Scopus (209) Google Scholar) was the that contained or a phosphorylation site for The resulting proteins were in and to phosphorylation by the site was The was and the C/EBPβ protein was used as a to a human protein from as The histone-lysine N-methyltransferase, H3 lysine 9-specific 3 was as an interacting protein between G9a and C/EBPβ was confirmed by with TAD and in G9a, as shown in of G9a and C/EBPβ showed that G9a and G9a mutant the interact with C/EBPβ in between endogenous C/EBPβ and G9a was confirmed in the cell that proteins between G9a and C/EBPβ on and was also found to be for the as shown in G9a the C/EBPβ were with as a to C/EBPβ in vivo. The was in the or of the which of the C.J. M. Li C. J. 2004; PubMed Scopus Google Scholar), and in the of and to protein Metabolic labeling with was used to of protein translation in the of of C/EBPβ and and a C/EBPβ in the but not in the of and that C/EBPβ post-translationally in vivo. G9a can methylate C/EBPβ. G9a or the mutant was as proteins in and from cell G9a proteins were with or in the of shown in C/EBPβ was by G9a but not by of G9a served as an for the activity of the M. J. D. S. 2007; PubMed Scopus (87) Google Scholar). of the amino acid of the C/EBPβ TAD between and a single conserved lysine residue in and in in the region between and Methylation with were with the C/EBPβ TAD to a G9a methylation target and served as a A that C/EBPβ other that may or may not lysine residues and The data that G9a that the conserved in methylation with proteins and G9a were was in wild type was by data that of C/EBPβ as a target site for G9a methylation. The G9a for of C/EBPβ functional of the interaction between C/EBPβ and G9a was by reporter gene G9a, but not the transactivation potential of C/EBPβ in a on the reporter A and A with the C/EBPβ TAD and the domain of (11Kowenz-Leutz E. Twamley G. Ansieau S. Leutz A. Genes Dev. 1994; 8: 2781-2791Crossref PubMed Scopus (209) Google Scholar) was also repressed by G9a The to reporter suggesting that the activity of G9a is important for by G9a on as its the G9a exchange of the conserved lysine at position 39 to also abrogated the these data that of G9a by and methylation of lysine 39 by G9a are for of the gene activation potential of C/EBPβ. The possibility that of methylation at C/EBPβ was by with wild type C/EBPβ or and activation of the C/EBPβ target gene (11Kowenz-Leutz E. Twamley G. Ansieau S. Leutz A. Genes Dev. 1994; 8: 2781-2791Crossref PubMed Scopus (209) Google Scholar). shown in the mutant in activation of suggesting that of methylation C/EBPβ to of C/EBPβ and G9a with the of the it has been shown that C/EBPβ may gene and that C/EBPβ can be by or phosphorylation of an conserved protein kinase site in its regulatory domain (9Nakajima T. Kinoshita S. Sasagawa T. Sasaki K. Naruto M. Kishimoto T. Akira S. Proc. Natl. Acad. Sci. U. S. A. 1993; 90: 2207-2211Crossref PubMed Scopus (514) Google Scholar, E. Twamley G. Ansieau S. Leutz A. Genes Dev. 1994; 8: 2781-2791Crossref PubMed Scopus (209) Google Scholar, 12Williams S.C. Baer M. Dillner A.J. Johnson P.F. EMBO J. 1995; 14: 3170-3183Crossref PubMed Scopus (199) Google Scholar). of C/EBPβ is accompanied by a conformational change that is to the TAD (13Mo X. Kowenz-Leutz E. Xu H. Leutz A. Mol. Cell. 2004; 13: 241-250Abstract Full Text Full Text PDF PubMed Scopus (136) Google Scholar). and functional interactions between G9a and C/EBPβ and on the human target gene that can be by in the cell J. S. M. M. 2006; PubMed Scopus Google Scholar, I. M. 1997; PubMed Google Scholar). shown in of of the gene and phosphorylation of C/EBPβ at between G9a and C/EBPβ was abrogated C/EBPβ This that in C/EBPβ that repression also interaction with G9a and C/EBPβ at the A of the has been as a that is J. S. M. M. 2006; PubMed Scopus Google Scholar). shown in in C/EBPβ and G9a were associated with the but not with an In addition, a of G9a was found at the but acetylation and phosphorylation be detected of abrogated G9a and and C/EBPβ, acetylation, and phosphorylation these data that at the gene and that G9a is from the during gene The Lysine G9a with was in a proteome-wide as an interaction of C/EBPβ, and the was found to be conserved and of the domain of the G9a that may function as a interaction The G9a were shown to and in histone H3 tails J.R. X. X. Mol. Biol. PubMed Scopus Google Scholar). G9a a protein lysine that may its and its the same methylation of C/EBPβ by G9a creates an site for G9a or other repressive is also that the long C/EBPβ isoforms LAP* and LAP may G9a and repression (7Screpanti I. Musiani P. Bellavia D. Cappelletti M. Aiello F.B. Maroder M. Frati L. Modesti A. Gulino A. Poli V. J. Exp. Med. 1996; 184: 1561-1566Crossref PubMed Scopus (57) Google Scholar, 8Lamb J. Ramaswamy S. Ford H.L. Contreras B. Martinez R.V. Kittrell F.S. Zahnow C.A. Patterson N. Golub T.R. Ewen M.E. Cell. 2003; 114: 323-334Abstract Full Text Full Text PDF PubMed Scopus (359) Google Scholar), is in in this is that the repressive of G9a C/EBPβ is observed methylation of may although G9a to C/EBPβ of This may that methylation of C/EBPβ by G9a creates a site for a repressive protein or interaction with C/EBPβ and by histone H3 methylation in its are by the of wild type with and by immunoprecipitation of endogenous C/EBPβ and G9a proteins on the gene in Methylation of a of in this identify lysine methylation at as a post-translational modification in C/EBPβ. The conserved is part of the transactivation domain of C/EBPβ and is in a region between and Lysine methylation of nuclear proteins was detected in but is that non-histone proteins are also to by methylation of lysine side chains in a p53 was shown to be in the part of the protein by the histone and (32Chuikov S. Kurash J.K. Wilson J.R. Xiao B. Justin N. Ivanov G.S. McKinney K. Tempst P. Prives C. Gamblin S.J. Barlev N.A. Reinberg D. Nature. 2004; 432: 353-360Crossref PubMed Scopus (626) Google Scholar, 33Huang J. Perez-Burgos L. Placek B.J. Sengupta R. Richter M. Dorsey J.A. Kubicek S. Opravil S. Jenuwein T. Berger S.L. Nature. 2006; 444: 629-632Crossref PubMed Scopus (479) Google Scholar, J. Sengupta R. M.G. Dorsey J.A. Richter M. Opravil S. R. Jenuwein T. Berger S.L. Nature. 2007; PubMed Scopus Google Scholar). Methylation of p53 may or transcription in a target by its activity J. Sengupta R. M.G. Dorsey J.A. Richter M. Opravil S. R. Jenuwein T. Berger S.L. Nature. 2007; PubMed Scopus Google Scholar). also at a single lysine This modification leads to a of the protein factor with the A. E. A. L. I. Mol. Cell. 2004; 14: Full Text Full Text PDF PubMed Scopus Google Scholar). The acid was also found to be in its domain. This modification to the of acid to interact with Mol. Cell. 2007; Full Text Full Text PDF PubMed Scopus Google Scholar). the lysine methylation of C/EBPβ also the interaction with that have to be G9a Lysine Methylation of of lysine in histone H3 as a site for protein and is with transcriptional gene and G9a methylate and and G9a between and G9a to be the in as of G9a in methylation in M. K. M. J. T. M. M. N. H. H. Y. Genes Dev. 2002; PubMed Scopus Google Scholar). G9a with as a and is for methylation of throughout M. H. D. X. Y. X. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar), the of methylation of S. F. D. Sun M. Opravil S. K. Allis C.D. Jenuwein T. Nature. 2000; PubMed Scopus Google Scholar) and M.D. Li J. J. Mol. Cell. Biol. PubMed Scopus Google Scholar). showed that G9a is of di-, and that the of H3 in although the is M. H. D. X. Y. X. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar, D. J. S.E. S. J. Biol. Chem. 2004; 279: Full Text Full Text PDF PubMed Scopus Google Scholar). G9a was shown to be in which not the enzymatic but the of G9a to M. J. D. S. 2007; PubMed Scopus (87) Google Scholar). may that repressive can on non-histone proteins methylation by reporter showed a and repression of C/EBPβ activity by the murine of was found to be and acetylation was to the transactivation potential of C/EBPβ (26Cesena T.I. Cardinaux J.R. Kwok R. Schwartz J. J. Biol. Chem. 2007; 282: 956-967Abstract Full Text Full Text PDF PubMed Scopus (79) Google Scholar). activation was from that transactivation in C/EBPβ and on sites (26Cesena T.I. Cardinaux J.R. Kwok R. Schwartz J. J. Biol. Chem. 2007; 282: 956-967Abstract Full Text Full Text PDF PubMed Scopus (79) Google Scholar). the between data and the but possibility is that post-translational modifications on C/EBPβ in a the acetylation of the C/EBPβ TAD at be associated with transcriptional activation and lysine methylation with a site that is involved in C/EBPβ activity dependent on the for with and for with
56
Regulation of chromatin structure by site-specific histone H3 methyltransferases
Stephen Rea, Frank Eisenhaber, Dónal O’Carroll et al. · Nature · 2000 · 2.8K citations
Regulation of p53 activity through lysine methylation
Sergei Chuikov, Julia K. Kurash, J. Wilson et al. · Nature · 2004 · 809 citations